heavily pretreated

Related by string. * HEAVILY . Heavily : heavily fortified Green . heavily armed . Heavily Indebted Poor . leaned heavily . leans heavily . borrows heavily . heavily fortified border . heavily favored / pretreating : pretreating taxiways . docetaxel pretreated . pretreated roads . pretreat roads . pretreating roads . pretreating sour crude . pretreated * heavily pretreated patients *

Related by context. Frequent words. (Click for all words.) 72 metastatic renal cell carcinoma 70 resistant ovarian cancer 69 chronic lymphocytic leukemia CLL 69 azacitidine 68 refractory multiple myeloma 68 evaluable 67 lupus nephritis 67 IMGN# 67 sunitinib 67 castration resistant prostate cancer 67 NSCLC 67 HRPC 67 gefitinib 66 hematologic cancers 66 HCV infected 66 evaluable patients 66 advanced NSCLC 66 tumor shrinkage 66 vandetanib 66 imetelstat 66 dasatinib 65 nilotinib 65 solid tumors 65 brain metastases 65 unresectable 65 biologic therapy 65 HGS ETR1 65 CA4P 65 HCV genotype 1 65 vinorelbine 65 temozolomide 64 antitumor activity 64 imatinib 64 AP# [003] 64 talactoferrin 64 free survival PFS 64 tumor regression 64 chronic HCV infection 64 HER2 positive breast cancer 64 sustained virologic response 64 limiting toxicity 63 Phase 2a trial 63 sorafenib 63 anti TNF 63 Median survival 63 liver metastases 63 gemcitabine 63 hematologic malignancies 63 adjuvant therapy 63 DLBCL 63 hypercalcemia 63 B CLL 63 BAY #-# 63 bone metastasis 63 cutaneous T cell 63 chemoradiation 63 bortezomib 63 TREANDA 62 TORISEL 62 hematological malignancies 62 HER2 positive 62 docetaxel 62 adalimumab 62 tumor recurrence 62 mitoxantrone 62 Phase Ib 62 topotecan 62 relapsing remitting multiple sclerosis 62 dose escalation 62 metastatic colorectal cancer 62 ofatumumab 62 dose limiting toxicities 62 trastuzumab 62 GvHD 62 median PFS 62 peginterferon 62 thromboembolic events 62 DMARDs 62 glioblastoma 62 myelofibrosis 62 infliximab 61 chronic myeloid leukemia CML 61 RECIST criteria 61 hormone refractory prostate cancer 61 chemotherapy regimens 61 FOLFOX 61 carboplatin 61 metastatic melanoma 61 HCV infection 61 diabetic nephropathy 61 LMWH 61 erlotinib 61 perifosine 61 rituximab 61 cetuximab 61 VIDAZA 61 nonresponders 61 eltrombopag 61 relapsing remitting 61 Torisel 61 pharmacodynamic

Back to home page